Blog
Would cancer make an exception for a Hollywood star?
Cancer does not make exceptions. This disease is unexpected and can affect each and every one of us… even Hollywood stars. Read the latest from blogs and around the web, including reactions to Angelina Jolie's article and personal stories of hope, persistence and inspiration.
We all react differently to cancer
Have you ever considered what you would do if you discovered that you had cancer? And if you have, how did you react when you learned about it? How does such knowledge change your attitude towards life? People with cancer react in different ways. Some of them try to understand the disease and find a way to stay strong and keep fighting. On the other hand, there are patients who don’t even try to recover. Read the following stories and you will understand exactly what I mean.
We are not “Cancer patients”, we are “Cancer fighters”
“When cancer reached the gate of my life, I decided to fight back and not let it steal my dreams. I decided to strike with power and no matter how many injuries and scars I got, I would win that battle, because it was the battle of my life”.
Colon cancer: treatment options, genetic testing and biomarkers
Colon cancer is one of the most common types of cancer. We asked Professor Hans-Joachim Schmoll, a member of the CareAcross Scientific Committee and a very experienced medical oncologist a few questions on treatment options, genetic testing and biomarkers.
Multiple Myeloma: genetics and treatment options
Professor Heinz Ludwig, member of the CareAcross Scientific Committee, is an expert in multiple myeloma, based in Austria. During our interview with him, he answered a few questions on the latest developments that are important for all multiple myeloma patients.
A world expert in lung cancer research answers our questions
Federico Cappuzzo is an expert in personalized treatment for lung cancer. We recently asked him to address important issues for patients’ lung cancer screening and treatment.
Targeted lung cancer treatment: interview with world-renowned expert
Targeted therapy is a new development in oncology, which attacks cancer cells but does less damage to normal cells. Professor Tony Mok, a member of the CareAcross Scientific Committee, is an expert in targeted treatments for lung cancer. In this article, he answers 4 important questions relevant to anyone affected by lung cancer.
Interview with Dr Enriqueta Felip on Lung Cancer
Dr. Enriqueta Felip, member of the CareAcross Scientific Committee, is a renowned expert in lung cancer. She holds a PhD in Medical Oncology, and has broad experience in cancer research as well as clinical practice. We recently asked her a few questions on lung cancer, and here are her responses.
More therapeutic options for metastatic melanoma patients
Melanoma is the most dangerous type of skin cancer. Our Chief Medical Officer reports the latest developments on metastatic melanoma, from the European Oncology conference.
Do tomatoes reduce prostate cancer risk?
With prostate cancer awareness growing around the world, perhaps the most frequently asked question is “Do tomatoes prevent prostate cancer?”. An endocrinologist who has studied the topic of nutrition and cancer at length provides some further details.
Latest lung cancer findings from the European oncology congress
Lung cancer is the most deadly cancer worldwide, claiming the lives of more than 1.5 million people annually. Our Chief Medical Officer attended the 2014 Congress of the European Society for Medical Oncology (ESMO) and summarizes the key findings.
“Unprecedented” improvement for HER2-positive metastatic breast cancer patients
HER2-positive accounts for 1 in 4 breast cancer cases. Metastatic disease is particularly challenging, and researchers have been trying to find a way to support these patients. A new combination of drugs was found very beneficial in a study, and this could help thousands of women worldwide.
Enjoy the sun without risking your health
Protecting your skin while in the sun is important, and we want you to enjoy sunshine without worrying. Our editors provide information on sun protection basics.
New treatments of lung adenocarcinoma with genetic mutations
A session at the 2014 ASCO meeting focused on targeted adenocarcinoma treatment for specific genetic mutations-a promising option for some lung cancer patients.
A mother, a grandmother, a winner
A routine examination showed throat cancer. Another tumor, in the left lung, made her fear she wouldn’t make it. 5 years later, she tells us how she made it.
Lung cancer statistics: latest information
At the European Lung Cancer Conference, new information on lung cancer incidence, key factors and genetic mutations were discussed. We present the highlights.
A raft which vanishes into the boundless ocean of tomorrow
Emily writes about the adventures of childhood cancer and the changes she experienced after 3 years of treatment. For her, life has no rules - only lessons.
After leukemia, a vision for life
The biggest win for Manos so far has been his victory against leukemia. That win is his compass. 21 years later, it brings him a unique gift: a vision for life.
Do you ever pretend cancer never happened?
Acute Lymphoblastic Leukemia made John more mature. And when he was cured, he understood his potential. Now, his suggestion is clear: do not deny your illness.
New radiotherapy method effective in early stage lung cancer
Stereotactic body radiotherapy has been found effective for early stage lung cancer patients who cannot undergo surgery due to risk from other health issues. Our Chief Medical Officer provides an analysis of the recent clinical findings.
How my support network helped cure my testicular cancer
This young man was about to stop chemotherapy for testicular cancer. His wife, together with his family and doctors, helped him through the side effects.
“A great gift-and I'm responsible for every minute of it”
20 years after a leukemia diagnosis, the moments are strong, but the feelings are stronger. Elpida shares her story, and her view of the ultimate gift: Life.
Ovarian cancer treatment & prevention: promising new approaches
Genetic analysis is an emerging field of cancer research. For ovarian cancer, such research can lead to better prevention and more effective treatments. Our Chief Medical Officer provides the latest details.
Childhood cancer survivors: the social impact in adulthood
The 12th PanCare Meeting for Childhood Cancer survivors was held in Amsterdam, and one session focused on social outcomes. Sabine Karner, PanCare board member, summarizes its main findings.
Triple negative: My cancer - not me!
Imagine taking a shower, and as you dream about the summer holiday planned to begin the following day, you feel a lump. Evangelia was strong enough to go to the doctor the next day, and not the islands. That, together with her positive attitude, may have saved her life.
Colon cancer: when should chemotherapy follow surgery?
Some patients with stage 2 colon cancer will recur after surgery. Our Chief Medical Officer provides detail on when post-surgery chemotherapy is likely to help treatment.
Statins reduce prostate cancer mortality
Statins are normally used to lower cholesterol (which is seemingly irrelevant to prostate cancer). However, cholesterol controls pathways related to prostate cancer cells’ survival. In article, our Chief Medical Officer describes the potential benefit to prostate cancer patients, based on two recently published studies.
Lung cancer adenocarcinoma patients benefit from personalized treatment
Adenocarcinoma is the most common type of non-small cell lung cancer. Our Chief Medical Officer explains the benefits from the latest research on targeted drugs.
Can nutrition help prevent cervical cancer?
Can we prevent cervical cancer through proper diet and nutrition? We present some of the research on correlating food and this gynecological cancer.
Childhood cancer survivors speak up at the 2013 Cancer Congress
The 2013 European Cancer Congress included sessions on childhood cancer survivors. Mrs Tsirou, the president of the childhood cancer survivors’ association called “Kyttaro” (based in Greece), summarizes the main findings and observations.